EUVIMEDEUVIMED entdecken
Crossref

Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring

Lu Wang, Ruiyue Chen, Zhiyong Liu, Dongtao Zhou, Yanyin Zhang, Chao Teng, Bangshun He, Yi Yin, Yanfeng Gao iD, Jingjing Yang iD, Meng Wang, Yujun Song iD

ACS Nano · 2026

DOI: 10.1021/acsnano.6c00255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Lu Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric and Hernia Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytica…. Hauptthemen laut MEDLINE: Biosensing Techniques, Neoplasms, Biomarkers, Tumor, DNA-(Apurinic or Apyrimidinic Site) Lyase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, National Key Research and Development Program of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate, real-time, noninvasive longitudinal diagnostic tools are essential for guiding personalized cancer therapy, and urine-based platforms represent a promising noninvasive avenue for continuous therapeutic monitoring. However, conventional approaches relying on passive detection of tumor-derived biomarkers shed into urine are often limited by physiological instability, low abundance, and poor specificity. Herein, we present a dual-enzyme-powered nanosensor for urine-based diagnostics that integrates apurinic/apyrimidinic endonuclease 1 (APE1)-triggered strand cleavage and telomerase (TE)-mediated extension to amplify the signal, enabling visual detection of tumor-associated enzymatic activity via a lateral flow assay (LFA). The nanosensor is constructed by assembling gold nanoclusters (AuNCs) with a synthetic DNA probe (A1T2) and encapsulating the complex with hyaluronic acid (HA). The AuNCs exhibit intrinsic fluorescence and enhanced DNA stability, thereby enabling structural integrity and real-time monitoring. The A1T2 strand is engineered with recognition motifs for APE1 and TE, which mediate sequential DNA cleavage and extension under pathological enzyme overexpression. Upon activation, the nanosensor is enzymatically processed, leaving a AuNC-tagged short single strand that is excreted into urine and detected by a competitive LFA strategy. This enables direct, visual, and instrument-free readout. The synergistic action of APE1 and TE confers a competitive advantage on the DNA substrate, leading to enhanced chromogenic shifts on test strips and improved visual resolution. This strategy translates intracellular enzyme activity into stable urinary signals and demonstrates the potential for low-cost, instrument-free companion diagnostics for personalized cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNeoplasmsBiomarkers, TumorDNA-(Apurinic or Apyrimidinic Site) LyaseTelomeraseHumansGoldMetal NanoparticlesHyaluronic Acid

Stichwörter der Autor:innen

early diagnosisengineered biomarkermicrofluidicspersonalized medicinepoint-of-care

Substanzen

GoldBiomarkers, TumorDNA-(Apurinic or Apyrimidinic Site) LyaseTelomeraseAPEX1 protein, humanHyaluronic Acid

Autor:innen und Institutionen

  • Department of Gastric and Hernia Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, Chin…
  • Institute of Critical Materials for Integrated Circuits, Shenzhen Polytechnic University, Shenzhen 518055, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
  • Division of Colorectal Surgery, Department of General Surgery, Nanjing University Medical School Affiliated Drum Tower Hospital, Nanjing 210023, China.
  • School of Medical Imaging, Wannan Medical University, Wuhu 241002, China.
  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Yanfeng Gao, Jingjing Yang, Yujun Song

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Shenzhen Polytechnic
  • National Natural Science Foundation of China
  • State Key Laboratory of Analytical Chemistry for Life Science

Zitieren

APA

Wang, L., Chen, R., Liu, Z., Zhou, D., Zhang, Y., Teng, C., He, B., Yin, Y., Gao, Y., Yang, J., Wang, M., & Song, Y. (2026). Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring. ACS Nano. https://doi.org/10.1021/acsnano.6c00255

Vancouver

Wang L, Chen R, Liu Z, Zhou D, Zhang Y, Teng C, et al. Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring. ACS Nano. 2026. doi:10.1021/acsnano.6c00255

BibTeX
@article{Wang2026,
  author = {Wang, Lu and Chen, Ruiyue and Liu, Zhiyong and Zhou, Dongtao and Zhang, Yanyin and Teng, Chao and He, Bangshun and Yin, Yi and Gao, Yanfeng and Yang, Jingjing and Wang, Meng and Song, Yujun},
  title = {Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c00255}
}
Kostenlos starten →